Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15910073 | 1.00 | CYP2C19 (0.33) | CYP2C19 | |
| SCHEMBL14557461 | 1.00 | CYP2C19 (0.33) | CYP2C19 | |
| SCHEMBL19046592 | 0.94 | — | — | |
| SCHEMBL15850760 | 0.80 | — | — | |
| SCHEMBL17694160 | 0.80 | CYP2C19 (0.31) | CYP2C19 | |
| SCHEMBL12410329 | 0.80 | CYP2C19 (0.31) | CYP2C19 | |
| SCHEMBL2600729 | 0.78 | — | — | |
| SCHEMBL10017886 | 0.77 | — | — | |
| SCHEMBL17126836 | 0.77 | — | — | |
| SCHEMBL17069142 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020239593-A1 | SILYL TERMINATED PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020239596-A1 | PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020239592-A1 | SILYL TERMINATED PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| US-20110166127-A1 | Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds | ARQULE, INC. (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166127-A1 | Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds | THPO, DHFR, BRD4 | CYP2C19 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.